NCT02627222

Brief Summary

The study comprises an open-label randomized controlled trial investigating the efficacy of consuming a daily ration of pro-vitamin A biofortified cassava on vitamin A status of Nigerian children, aged 3-4 years old (n=200).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
176

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

December 8, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 10, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

February 5, 2020

Status Verified

January 1, 2020

Enrollment Period

5 months

First QC Date

December 8, 2015

Last Update Submit

January 31, 2020

Conditions

Keywords

Pro-vitamin ACassavaVitamin A deficiencyRetinol Isotope DilutionPreschool childrenNigeria

Outcome Measures

Primary Outcomes (2)

  • Body retinol pool (omitted)

    Difference in body retinol pools between groups

    13 weeks

  • (Modified primary outcome): Serum retinol

    Difference in serum retinol pools between groups

    13 weeks

Secondary Outcomes (2)

  • Anaemia

    13 weeks

  • Gut integrity

    11 weeks

Other Outcomes (8)

  • Serum betacarotene

    13 weeks

  • Retinol binding protein

    13 weeks

  • Urinary thiocyanate

    11 weeks

  • +5 more other outcomes

Study Arms (2)

Treatment

ACTIVE COMPARATOR

Daily consumption of two cassava-based meals prepared with pro-vitamin A rich biofortified cassava

Other: Pro-vitamin A biofortified cassava

Control

PLACEBO COMPARATOR

Daily consumption of two cassava-based meals prepared with common white cassava

Other: White cassava

Interventions

Pro-vitamin A biofortified cassava is the product of international conventional breeding programs (non-GMO) in order to increase the pro-vitamin A content of cassava for improved nutritional intake

Also known as: Yellow cassava, Biofortified cassava
Treatment

Conventional white cassava

Also known as: Cassava, Manihot esculenta
Control

Eligibility Criteria

Age36 Months - 59 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Aged 36 - 59 months (verified by birth certificates, vaccination cards or other formal documentation)
  • Apparently healthy
  • Parental informed consent

You may not qualify if:

  • Frequently absent (\>20% of feeding days) during run-in
  • Children not assenting during blood collections
  • Signs or history of infectious or systemic diseases (e.g. tuberculosis, sickle cell anaemia)
  • Mental status that is incompatible with the proper conduct of the study
  • Current participation in other research
  • Food allergy related to the intervention foods

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Human Nutrition, University of Ibadan

Ibadan, Nigeria

Location

Related Publications (1)

  • Afolami I, Mwangi MN, Samuel F, Boy E, Ilona P, Talsma EF, Feskens E, Melse-Boonstra A. Daily consumption of pro-vitamin A biofortified (yellow) cassava improves serum retinol concentrations in preschool children in Nigeria: a randomized controlled trial. Am J Clin Nutr. 2021 Jan 4;113(1):221-231. doi: 10.1093/ajcn/nqaa290.

MeSH Terms

Conditions

Vitamin A Deficiency

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Alida Melse-Boonstra, PhD

    Division of Human Nutrition, Wageningen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2015

First Posted

December 10, 2015

Study Start

December 1, 2015

Primary Completion

May 1, 2016

Study Completion

December 1, 2016

Last Updated

February 5, 2020

Record last verified: 2020-01

Locations